State laws may limit implementation of CDC's recommendations for routine HIV testing

October 09, 2007

A new study concludes that routine testing for HIV recommended by the Centers for Disease Control (CDC) may violate many state laws. The study, published on October 10 in the online, open-access journal PLoS ONE), found that more than thirty states require specific consent before HIV testing may occur. Nearly half of them require that consent to be in writing.

Those state laws stand in contrast to recommendations issued by the CDC in 2006, recommending routine HIV testing for all Americans between ages 13 and 64. According to the CDC, adults should be tested, after notification, unless they refuse. Organizations around the country are now considering how to implement the CDC's recommendations.

Researchers, led by Leslie Wolf at Georgia State University College of Law's Center for Health, Law and Society, learned that almost half the states require disclosure of specific information about HIV to patients before testing. Required disclosures include information describing how HIV is transmitted, what people can do to protect themselves from getting the disease, and what will be done with test results. These requirements were adopted to encourage testing when the HIV test first became available in the 1980s. Professor Wolf and her colleagues found that states that have recently amended their HIV laws have kept these requirements, despite the CDC recommendations.

Wolf and her colleagues contend that HIV testing practices are unlikely to change without better understanding of why states have retained requirements for specific consent and pre-test counseling. They suggest that under the limited disclosures contemplated by the CDC, patients may not have enough information to make an informed decision about HIV testing. In addition, eliminating requirements for pretest disclosures and counseling may remove an important mechanism for educating individuals about HIV and reducing risk of disease transmission.
-end-
Disclaimer

The following press release refers to an upcoming article in PLoS ONE. The release has been provided by the article authors and/or their institutions. Any opinions expressed in this are the personal views of the contributors, and do not necessarily represent the views or policies of PLoS. PLoS expressly disclaims any and all warranties and liability in connection with the information found in the release and article and your use of such information.

Contact:

Leslie E. Wolf, J.D., M.P.H.
Georgia State University
Email: lwolf@gsu.edu
Tel: +1 404-413-9164

Citation: Wolf LE, Donoghoe A, Lane T (2007) Implementing Routine HIV Testing: The Role of State Law. PLoS ONE 2(10): e1005. doi:10.1371/journal.pone.0001005

PLEASE ADD THE LINK TO THE PUBLISHED ARTICLE IN ONLINE VERSIONS OF YOUR REPORT (URL live from October 10): http://www.plosone.org/doi/pone.0001005

PRESS ONLY PREVIEW: http://www.plos.org/press/pone-02-10-wolf.pdf

PLOS

Related HIV Articles from Brightsurf:

BEAT-HIV Delaney collaboratory issues recommendations measuring persistent HIV reservoirs
Spearheaded by Wistar scientists, top worldwide HIV researchers from the BEAT-HIV Martin Delaney Collaboratory to Cure HIV-1 Infection by Combination Immunotherapy (BEAT-HIV Collaboratory) compiled the first comprehensive set of recommendations on how to best measure the size of persistent HIV reservoirs during cure-directed clinical studies.

The Lancet HIV: Study suggests a second patient has been cured of HIV
A study of the second HIV patient to undergo successful stem cell transplantation from donors with a HIV-resistant gene, finds that there was no active viral infection in the patient's blood 30 months after they stopped anti-retroviral therapy, according to a case report published in The Lancet HIV journal and presented at CROI (Conference on Retroviruses and Opportunistic Infections).

Children with HIV score below HIV-negative peers in cognitive, motor function tests
Children who acquired HIV in utero or during birth or breastfeeding did not perform as well as their peers who do not have HIV on tests measuring cognitive ability, motor function and attention, according to a report published online today in Clinical Infectious Diseases.

Efforts to end the HIV epidemic must not ignore people already living with HIV
Efforts to prevent new HIV transmissions in the US must be accompanied by addressing HIV-associated comorbidities to improve the health of people already living with HIV, NIH experts assert in the third of a series of JAMA commentaries.

The Lancet HIV: Severe anti-LGBT legislations associated with lower testing and awareness of HIV in African countries
This first systematic review to investigate HIV testing, treatment and viral suppression in men who have sex with men in Africa finds that among the most recent studies (conducted after 2011) only half of men have been tested for HIV in the past 12 months.

The Lancet HIV: Tenfold increase in number of adolescents on HIV treatment in South Africa since 2010, but many still untreated
A new study of more than 700,000 one to 19-year olds being treated for HIV infection suggests a ten-fold increase in the number of adolescents aged 15 to 19 receiving HIV treatment in South Africa, according to results published in The Lancet HIV journal.

Starting HIV treatment in ERs may be key to ending HIV spread worldwide
In a follow-up study conducted in South Africa, Johns Hopkins Medicine researchers say they have evidence that hospital emergency departments (EDs) worldwide may be key strategic settings for curbing the spread of HIV infections in hard-to-reach populations if the EDs jump-start treatment and case management as well as diagnosis of the disease.

NIH HIV experts prioritize research to achieve sustained ART-free HIV remission
Achieving sustained remission of HIV without life-long antiretroviral therapy (ART) is a top HIV research priority, according to a new commentary in JAMA by experts at the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health.

The Lancet HIV: PrEP implementation is associated with a rapid decline in new HIV infections
Study from Australia is the first to evaluate a population-level roll-out of pre-exposure prophylaxis (PrEP) in men who have sex with men.

Researchers date 'hibernating' HIV strains, advancing BC's leadership in HIV cure research
Researchers have developed a novel way for dating 'hibernating' HIV strains, in an advancement for HIV cure research.

Read More: HIV News and HIV Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.